Family · Pharmaceutical analytical standards
Methocarbamol
A centrally acting muscle relaxant developed in 1956 to improve on mephenesin, which was weak and short-acting, and approved in the United States in 1957 for acute, painful muscle spasms. This family brings together the active ingredient, metabolites, labelled standards and other impurities.
Did you know?It is the carbamate derivative of guaifenesin, the expectorant in many cough syrups, but it does not turn into guaifenesin. It can colour urine black, blue or green.
No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
